The skeletal effects of glucocorticoid excess override those of orchidectomy in mice

Endocrinology

Volumn 145, Issue 4, 2004, Pages 1980-1987

  Weinstein, Robert S ^a   Jia, Dan ^a   Powers, Cara C ^a   Stewart, Scott A ^a   Jilka, Robert L ^a   Parfitt, A Michael ^a   Manolagas, Stavros C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE; SEX HORMONE; TESTOSTERONE;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE DENSITY; BONE REMODELING; BONE STRENGTH; CANCELLOUS BONE; CELL ACTIVATION; CELL DIFFERENTIATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; ENDOCRINE DISEASE; HORMONE ACTION; HYPOGONADISM; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; ORGAN WEIGHT; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOID; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; SEMINAL VESICLE; SKELETON; STEM CELL; TESTOSTERONE BLOOD LEVEL; VERTEBRA;

ANIMALS; APOPTOSIS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CELL DIVISION; COMPRESSIVE STRENGTH; GLUCOCORTICOIDS; MALE; MICE; ORCHIECTOMY; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; PREDNISOLONE; SEMINAL VESICLES; SPINE;

EID: 1642546362     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1133     Document Type: Article

References (39)

1. Marcus R, Gopalakrishnan G 2002 Secondary forms of osteoporosis. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. 2nd ed. Chap 37. Philadelphia: Lippincott Williams and Wilkins; 847-864
2. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C 2000 Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
3. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of the deleterious effects on bone. J Clin Invest 102:274-282
4. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC 2002 Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041-1048
5. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS 2004 Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835-1841
6. Kream BE, Lukert BP 2002 Clinical and basic aspects of glucocorticoid action in bone. In: Bilezikian JP, Raisz LG, Rodan GA. eds. Principles of bone biology. Chap 41. 2nd ed. San Diego: Academic Press; 723-740
7. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC 1992 Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91
8. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC 1997 The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology 138:4013-4021
9. Kousteni S, Chen J-R, Bellido TM, Han LL, Ali AA, O'Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers C, Stewart SA, Ebert RH, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC 2002 Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843-846
10. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137
11. Lukert BP, Johnson BE, Robinson RG 1992 Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 7:1063-1069
12. Reid IR, Wattie DJ, Evans MC, Stapleton JP 1996 Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173-1177
13. Boulos P, Adachi JD 2000 Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 18(Suppl 21):S79-S86
14. Di Gregorio GB, Yamamoto M, Ali AA, Abe E, Roberson P, Manolagas SC, Jilka RL 2001 Attenuation of the self-renewal of transient-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol. J Clin Invest 107:803-812
15. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
16. Boyce BF, Xing L, Jilka RL, Bellido T, Weinstein RS, Parfitt AM, Manolagas SC 2002 Apoptosis in bone cells. In: Bilezikian JP, Raisz LG, Rodan GA. eds. Principles of bone biology. Chap 10. 2nd ed. San Diego: Academic Press; 151-168
17. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorlo GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotrophic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
18. StatCorp 2001 Stata Statistical Software Release 7.0. College Station, TX: Stata Corp.; vol 3:11-115
19. SAS Institute Inc. 1997 The MIXED procedure. In: SAS/STAT software: changes and enhancements through release 6.12. Chap 18. Cary, NC: SAS Institute Inc.; 571-702
20. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murry R, Manolagas SC 1995 Regulation of Interleukin-6, osteoclastogenesis, and bone mass by androgens: the role of the androgen receptor. J Clin Invest 95:2886-2895
21. Vanderschueren D, Boonen S, Ederveen AGH, De Coster R, Van Herck E, Moermans K, Vandenput L, Verstuyf A, Bouillon R 2000 Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Bone 27:611-617
22. Arantes-Oliveira N, Berman JR, Kenyon C 2003 Healthy animals with extreme longevity. Science 3020:611
23. Weinstein RS 1982 Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy. Calcif Tissue Int 34:16-20
24. Crilly R, Cawood M, Marshall DH, Nordin BEC 1978 Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women. J R Soc Med 71:733-736
25. MacAdams MR, White RH, Chipps BE 1986 Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 104:648-651
26. Montecucco C, Caporali R, Caprotti P, Caprotti M, Notario A 1992 Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids. J Rheumatol 19:1895-1900
27. Hampson G, Bhargava N, Cheung J, Vaja S, Seed PT, Fogelman I 2002 Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis. Metabolism 51:1458-1462
28. Pearce G, Tabensky DA, Delmas PD, Baker HWG, Seeman E 1998 Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 83:801-806
29. Rizzoni G, Ehrich JH, Broyer M, Brunner FP, Brynger H, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing AJ 1992 Successful pregnancies in woman on renal replacement therapy: report from the EDTA registry. Nephrol Dial Transplant 7:279-287
30. European Renal Association-European Dialysis and Transplantation Association 2002 IV. Section 10: pregnancy in renal transplant recipients: guidelines. Nephrol Dial Transplant Suppl 4:50-55
31. Turner RT, Hannon KS, Greene VS, Bell NH 1995 Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats. Calcif Tissue Int 56:311-315
32. Goulding A, Gold E 1987 Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving β-estradiol. Endocrinology 122:482-487
33. Dempster DW, Moonga BS, Stein LS, Horbert WR, Antakly T 1997 Glucocorticoids inhibit bone resorption by isolated osteoclasts by enhancing apoptosis. J Endocrinol 154:397-406
34. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM 1984 Osteoporosis in women with anorexia nervosa. N Engl J Med 311:1601-1606
35. Soyka LA, Misra M, Frenchman A, Miller KK, Grinspoon S, Schoenfeld DA, Klibanski A 2002 Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87:4177-4185
36. Garnero P, Sornay-Rendu, E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526-1536
37. Biller BMK, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A 1989 Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 68:548-554
38. Foster DW 1992 Eating disorders: obesity, anorexia nervosa, and bulimia nervosa. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology. Chap 25. 8th ed. Philadelphia: W. B. Saunders Co.; 1357
39. Carmichael KA, Carmichael DH 1995 Bone metabolism and osteoporosis in eating disorders. Medicine 74:254-267